Related Experiment Videos
Identification of a point mutation in factor XIII A subunit deficiency
P Board1, M Coggan, K Miloszewski
1Molecular Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra.
Blood
|August 15, 1992
Summary
Researchers identified a genetic mutation in the human coagulation factor XIII A subunit gene causing severe deficiency. This G to A transition at exon 14 may disrupt pre-messenger RNA splicing, impacting protein function.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Coagulation factor XIII (FXIII) is crucial for blood clot stabilization.
- FXIII A subunit deficiency leads to severe bleeding disorders.
- Understanding the genetic basis of FXIII deficiency is vital for diagnosis and treatment.
Observation:
- Oligonucleotide primers were designed to amplify all 15 exons of the human FXIII A subunit gene.
- Exon and flanking intron regions were sequenced from a patient with severe FXIII A subunit deficiency.
- A G to A transition mutation was found at the terminal base of exon 14 in the proband and heterozygous parents.
Findings:
- The identified mutation (G to A transition) is located at a critical splice junction in exon 14.
- This mutation is predicted to cause an Arg to His substitution at amino acid 681 in the FXIII A protein.
- The splice site mutation strongly suggests a defect in pre-messenger RNA splicing as the cause of FXIII deficiency.
Implications:
- The findings pinpoint a specific genetic defect responsible for FXIII A subunit deficiency.
- This discovery aids in understanding the molecular mechanisms underlying FXIII deficiency.
- Identifying the precise mutation facilitates genetic counseling and potential targeted therapies for affected individuals.